Prestige Biologics (Korea) Analysis

Prestige Stock Analysis Notes

The company had not issued any dividends in recent years. Prestige Biologics Co., Ltd. specializes in the development and production of biologic agents and biosimilars. The company was founded in 2015 and is based in Cheongju-si, South Korea. Prestige Biologics is traded on Korean Securities Dealers Automated Quotations in South Korea. For more info on Prestige Biologics Co please contact the company at 82 4 3232 1552 or go to http://pbpharma.co.kr.

Prestige Biologics Investment Alerts

Prestige Market Capitalization

The company currently falls under 'Mega-Cap' category with a current market capitalization of 198.91 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Prestige Biologics's market, we take the total number of its shares issued and multiply it by Prestige Biologics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Technical Drivers

As of the 18th of December 2024, Prestige Biologics holds the Variance of 17.61, risk adjusted performance of 0.0053, and Coefficient Of Variation of (24,105). Prestige Biologics technical analysis gives you tools to exploit past prices in attempt to determine a pattern that determines the direction of the company's future prices.

Prestige Biologics Price Movement Analysis

Prestige Biologics Predictive Daily Indicators

Prestige Biologics Forecast Models

Prestige Biologics' time-series forecasting models are one of many Prestige Biologics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Prestige Biologics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Prestige Biologics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Prestige shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Prestige Biologics. By using and applying Prestige Stock analysis, traders can create a robust methodology for identifying Prestige entry and exit points for their positions.

When running Prestige Biologics' price analysis, check to measure Prestige Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Prestige Biologics is operating at the current time. Most of Prestige Biologics' value examination focuses on studying past and present price action to predict the probability of Prestige Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Prestige Biologics' price. Additionally, you may evaluate how the addition of Prestige Biologics to your portfolios can decrease your overall portfolio volatility.